Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials

Author:

Zaragoza Domingo SilviaORCID,Alonso Jordi,Ferrer MontseORCID,Acosta Maria T.,Alphs Larry,Annas PeterORCID,Balabanov Pavel,Berger Anna-KarinORCID,Bishop Kim I.,Butlen-Ducuing FlorenceORCID,Dorffner Georg,Edgar Chris,de Gracia Blanco Manuel,Harel Brian,Harrison JohnORCID,Horan William P.,Jaeger Judith,Kottner Jan,Pinkham AmyORCID,Tinoco DaniellaORCID,Vance MonikaORCID,Yavorsky ChristianORCID

Funder

European College of Neuropsychopharmacology

Publisher

Elsevier BV

Reference52 articles.

1. Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments;Arnerić;Biochemical Pharmacology [Internet],2018

2. Beaton D, Maxell L, Grosskleg S, Shea B, Tugwell P. The OMERACT Handbook [Internet]. 2021. Available from: https://omeract.org/handbook/.

3. Proposal for Standardization of Clinical Outcomes Assessment Strategies for Early-Stage Drug Development Trials;Bishop;Innov Clin Neurosci,2023

4. COMET-Initiative. COMET-Initiative. 2017. COMET Proect 606. Available from: https://www.comet-initiative.org/Studies/Details/606.

5. ECNP COA Group. Clinical Outcomes Assessment Selection - Practical Guidance in Neuroscience Drug Development. V3 [Internet]. 2023. Available from: https://drive.google.com/file/d/10NRU1eIyGnMwCZgEfMqDUbwc9o0HqOG1/view?usp=drive_link.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3